Background: Thioredoxins (Trx) are small redox proteins that function as general
INTRODUCTION
Thioredoxins (Trx) are small ubiquitous proteins that are conserved in all organisms through evolution. They are characterized by the sequence of their highly conserved active site Cys-Gly-Pro-Cys (CGPC) and participate in different cellular mechanisms, mainly redox reactions by the reversible oxidation of their active site from the dithiol form to disulfide (Arner & Holmgren 2000; Powis & Montfort 2001) .
To be active, thioredoxins must be reduced and this state is maintained by the flavoenzyme thioredoxin reductase (TrxR) at expense of the reducing power of NADPH, thus forming the so-called thioredoxin system (Holmgren & Björnstedt 1995) . All organisms so far investigated contain several thioredoxins. Thus, E. coli has two thioredoxins, both cytosolic, and the lower eukaryote Saccharomyces cerevisiae has three, two cytosolic and one mitochondrial (Grant 2001; Laurent et al. 1964; MirandaVizuete et al. 1997a; Pedrajas et al. 1999) . The increasing complexity of higher eukaryotes is also reflected in the thioredoxin family. For instance, a homology search in Caernohabditis elegans and Drosophila melanogaster genomes identify up to eight proteins containing the active site WCGPC. The number of thioredoxins in mammalian organisms is lower although it is expected to increase once the human genome sequence has been fully searched. Currently, in humans there are three ubiquitous forms, Trx-1, Trx-2 and Txl-1 and only one tissue specific Sptrx expressed in spermatozoa (Holmgren & Björnstedt 1995; Miranda-Vizuete et al. 2000; MirandaVizuete et al. 1998; Miranda-Vizuete et al. 2001) .
Initially discovered as an electron donor for ribonucleotide reductase, an essential enzyme in DNA synthesis, many other functions have since then been ascribed to thioredoxins. They reduce other metabolic enzymes like PAPS reductase or methionine sulfoxide reductase, regulate transcription factor DNA binding activity, act as antioxidant molecules, modulate apoptosis and have also been implicated in many pathological situations (Powis & Montfort 2001) .
Based on protein sequence organization two distinct groups can be identified within the thioredoxin family. Group I includes those proteins that exclusively encode a thioredoxin domain while group II is composed of fusion proteins of thioredoxin domains plus additional domains. Among those belonging to group I are E. coli Trx-1, the three yeast thioredoxins or mammalian Trx-1 and Trx-2 (Grant 2001; Holmgren & Björnstedt 1995; Laurent et al. 1964; Spyrou et al. 1997) . Examples of group II thioredoxins are E. coli Trx-2, that has an N-terminal extension that resembles the structure of a zinc finger domain (Miranda-Vizuete et al. 1997a) or the DLC14 and DLC16 of Chlamydomonas reinhardtii flagellar outer dynein arm that possess a thioredoxin domain followed by a C-terminal extension of unknown function (Patel-King et al. 1996) . Also belonging to group II are mammalian Txl-1 and Sptrx which have additional domains displaying no homology with any other protein in the databases (Miranda-Vizuete et al. 1998; Miranda-Vizuete et al. 2001) .
Another member of group II is sea urchin IC1 protein, a sperm outer dynein arm intermediate chain which is composed of an N-terminal thioredoxin domain followed by three nucleoside diphosphate (NDP) kinase domains (Ogawa et al. 1996) .
NDP-kinase represents a large family of structurally and functionally conserved proteins from bacteria to humans also known as nm23 that, in general, catalyzes the transfer of γ-phosphates between nucleosides and deoxynucleoside di-and triphosphates, therefore playing a pivotal role in maintaining a balanced pool of nucleotides (Postel et al. 2000) . In humans, eight different members of the nm23 family have been reported to date (nm23-H1 to H8), and as with the thioredoxin family, nm23 proteins can also be classified into two groups based on sequence alignment and phylogenetic analysis . Group I is composed of nm23-H1 to H4, and is characterized by a similar genomic organization, the formation of hexamers of identical subunits and the classical enzymatic activity of NDP kinases. Group II encompasses nm23-H5 to H8 genes which are defined by a more divergent sequence, have an NDP kinase active site sequence that is not strictly conserved and have considerable variation in the lengths of their N-and C-terminal domains . Besides the kinase function, human nm23 proteins have been implicated in cell growth, tumor suppression metastasis and development (Lombardi et al. 2000) . In addition, nm23-H2 has been shown to be the transcription factor Puf for the proto-oncogene c-myc (Postel et al. 1993) . Most human nm23 proteins are found in cytosol, although nm23-H4 is shown to be a mitochondrial enzyme Milon et al. 2000) . Furthermore, nm23-H5, H6 and H8 have been shown to have a tissue-specific distribution, mostly expressed in human testis Munier et al. 1998) . We have described a similar situation in the thioredoxin family and have also identified mitochondrial and sperm specific members (Miranda-Vizuete et al. 2001; Spyrou et al. 1997) .
We report here the characterization of a novel member of the thioredoxin family, the second with a tissue specific distribution in human testis, termed Sptrx-2 based on its expression pattern in spermatozoa. The Sptrx-2 sequence has been independently deposited in public databases (GenBank entry NM_016616) as a member of the nm23 family (nm23-H8) due to the presence of three NDP kinase domains located at the Cterminus of the thioredoxin domain. Thus, Sptrx-2 must be classified as a member of the group II of thioredoxins. Sptrx-2 displays high homology with sea urchin IC1 (intermediate chain-1) protein, a component of the sperm axonemal outer dynein arm complex (Ogawa et al. 1996) . Taken together, Sptrx-2 appears to be a new component of the human sperm axoneme architecture and its possible role in human sperm motility and fertility is discussed.
RESULTS
cDNA cloning, sequence analysis, genomic organization and chromosomal localization of human Sptrx-2 gene. By sequence comparison we found that Genbank entry AF202051 encoded a putative novel human thioredoxin-like sequence. As no information regarding tissue expression was stated in this entry we performed a BLAST search in Genbank EST database to determine which cDNA library we should use to confirm AF202051 sequence. The search resulted in the identification of three matches from testis, total fetus and male germ cell tumors, respectively (GenBank entries: AL043096, AI077399 and AW590130). Therefore, we designed specific primers based on AF202051 sequence and performed 5'-and 3'-RACE PCR analysis in a human testis cDNA library to clone the full-length cDNA sequence of this novel protein. The complete sequence of the cDNA obtained consists of an ORF of 1767 bp, a 5'-UTR of 70 bp including two stop codons in frame and a 3'-UTR of 166 bp before the poly(A) + tail (Fig. 1) . Human Sptrx-2 ORF encodes a protein of 588 amino acids with an estimated molecular mass of 67.3 kDa and a pI of 4.82. It is interesting that Sptrx-1 pI (Miranda-Vizuete et al. 2001 ) is identical to that of Sptrx-2. Analysis of the human Sptrx-2 sequence identified two distinct domains: an Nterminal domain (comprising the first 105 residues) similar to thioredoxins and a Cterminal domain composed of three tandemly repeated NDP kinase domains ( Fig.   2A) . Interestingly, the Sptrx-2 protein domain organization resembles the one of IC1, an outer dynein arm of sea urchin axoneme (Ogawa et al. 1996) . Regarding the Nterminal thioredoxin domain, some of the structural amino acids that are conserved in previously characterized mammalian thioredoxins like Gly-91 (numbers referred to those of human Trx-1) are also conserved in Sptrx-2 (Fig.   2B ). However, other important residues shown to be essential for catalysis, maintenance of three-dimensional structure or protein-protein interactions are changed, for instance Phe-11, Ala-29, Asp-58 or Lys-81 (Eklund et al. 1991) . The alignment of all known human thioredoxins was used to perform a phylogenetic analysis including a novel thioredoxin-like protein, named Txl-2 1 . As shown in Figure 3A and 3B, mitochondrial thioredoxin (Trx-2) separates from the rest of the human thioredoxins quite early in evolution and the remaining members are clustered into three different groups: Trx-1 and Sptrx-1, Sptrx-2 and Txl-2, and finally
Txl-1. Sptrx-1 is a retrogene originating from human Trx-1 mRNA; whereas, Sptrx-2 and Txl-2 have identical intron/exon organization 1 suggesting they have originated from a genomic duplication event. Txl-1 is placed alone in an independent branch.
Additionally, the Sptrx-2 C-terminal domain consists of three repeats of an NDP kinase domain. The first domain (NDPk-A) is truncated while the second and third (NDPk-B and NDPk-C) are complete ( Fig. 2A) . As noted previously, Sptrx-2 has also been reported as a novel member of the NDP kinase family of proteins, termed nm23-H8. However, no published report on this protein has been done except a brief mention in a review . In this review, a protein alignment and phylogenetic analysis of all human NDP kinase domains is done, showing that the Sptrx-2 NDPk-B and NDPk-C domains belong to NDP kinase group II.
In X-ray crystallography and site-directed mutagenesis studies, nine residues essential for catalysis and stability of nm23 proteins have been identified Lombardi et al. 2000) . Surprisingly, the Sptrx-2 NDPk-B domain only has two out of nine conserved residues while the NDPk-C domain has seven conserved residues regarded as crucial for enzymatic activity. Furthermore, the sequence of the active site in the NDPk-B domain (NXXY) is different from the remaining nm23
proteins (NXXH) where X can be any residue ( Fig. 2A) .
Comparison of the protein sequence with PROSITE database (Bairoch et al. 1997 ) identified, along with the above mentioned thioredoxin and NDP kinase domains, several potential phosphorylation sites for protein kinases CKI, CKII, GSK3
and PKC with only one potential site for PKA. In addition, a highly scored PEST sequence for proteasome-dependent degradation centered at position 242 (Fig. 1) .
A homology search in GenBank identified Sptrx-2 genomic region in the genomic BAC clone AC018634. Sptrx-2 gene spans about 51 kb and is organized into 17 exons and 16 introns all of them conforming to the GT/AG rule (Table 1) . Finally, the BAC clone AC018634 has been mapped to human chromosome 7p13-14, between the markers D7S485 and D7S528, by PCR screening of a human-rodent radiation panel.
Tissue and cellular expression of human Sptrx-2 mRNA. Multiple-tissue
Northern blots were used to determine the size and tissue distribution of human Sptrx-2 mRNAs using the ORF as the probe. Human Sptrx-2 mRNA was only detected in human testis as a single band of approximately 2.4 kb in good agreement with the size of the cloned cDNA (Fig. 4) . It should be noted that a very long exposure of the blots was required to identify the hybridization signal which suggests that Sptrx-2 mRNA might not be expressed at high levels, consistent with the low number (three) of matching EST sequences in the human database. To evaluate the possibility that Sptrx-2 mRNA could be expressed in other tissues not present in these blots, we also screened an RNA dot blot containing poly ( . To evaluate whether this was also the case for Sptrx-2 we performed a gel filtration chromatography and found that the protein migrates as a monomer (Fig. 6 ).
Enzymatic activity of thioredoxins is usually assayed by their capacity to reduce the disulfide bonds of insulin using either DTT as artificial reductant or NADPH and thioredoxin reductase as a more physiological reducing system (Arner & Holmgren 2000) . We were unable to detect any Sptrx-2 enzymatic activity using calf thymus thioredoxin reductase and NADPH with either the full-length protein or the truncated form (data not shown). However, when using DTT as reductant we were able to detect activity with the truncated form expressing only the thioredoxin domain. When compared with human Trx-1 used as control, truncated Sptrx-2 displayed a similar enzymatic activity profile although at a 1:5 molar ratio and with a marked latency phase (Fig. 7) . Taken together, these data suggest that Sptrx-2 is not an efficient protein disulfide reductase in vitro.
NDP kinases catalyze the transfer of a terminal phosphate residue from NTPs to NDPs according to a ping-pong mechanism. The first step of this reaction consists of the autophosphorylation of the enzyme at a conserved histidine of the active site (Biondi et al. 1996; Lecroisey et al. 1995) . As noted above, the NDPk-C domain of Sptrx-2 has the typical active site sequence NXXH while the NDPk-B domain has a substitution of the histidine residue by a tyrosine, which might also be phosphorylated ( Fig. 2A ). However, Sptrx-2 is unable to undergo autophosphorylation under the same experimental conditions that allowed positive control yeast NDP kinase autophosphorylation (data not shown) .
To assess the possibility that Sptrx-2 could display enzymatic activity in an in vivo system we overexpressed human Sptrx-2 in HEK293 cells by transient transfections experiments. Cells overexpressing full-length Sptrx-2 did not show significant differences on enzymatic activity over the control values, due to the high levels of endogenous thioredoxin activity (data not shown).
Tissue expression and cellular and subcellular localization of human Sptrx-2 protein. Affinity-purified antibodies were used to study the expression pattern of human Sptrx-2 protein in different human tissues and cell lines. As shown in Figure   8A , only human testis and sperm extracts expressed Sptrx-2 as a band of approximately 67 kDa in good agreement with the migration of the recombinant protein in SDS gels. No signal was detected in any other tissue or cell line used as control, including those harbouring flagella tissues like lung and trachea. The antibodies also recognized a band of similar size in rat, mouse and bull testis extracts (data not shown). To address the question of whether Sptrx-2 protein distribution paralleled the mRNA expression, we performed immunohistochemical analysis in human testicular sections that revealed that Sptrx-2 expression was restricted to spermiogenesis, starting at the pachytene spermatocytes level and peaking at the round and elongating spermatid stage ( Figure 8B ). Other testicular cell types like spermatogonia, Sertoli and Leydig cells were devoid of signal. Immunofluorescence analysis of human ejaculated spermatozoa identifies Sptrx-2 signal localized from the caudal region of the head to the end of the principal piece of sperm tail ( Figure 8C ).
To determine whether Sptrx-2 protein might be targeted to any subcellular compartment during spermiogenesis, we constructed plasmid vectors to express it as a fusion protein carrying GFP at its C-terminus. The plasmid was transiently transfected into HEK293 cells and the fluorescent fusion protein detected by confocal microscopy. Cells transfected with the control plasmid expressing only the GFP protein showed fluorescence in both cytosol and nucleus, as its small size (27 kDa) allows it to translocate into the nucleus passively (data not shown). The fusion protein Sptrx-2/GFP showed a clear cytosolic distribution although a weaker punctuated pattern could also be found in the nucleus (Fig. 9A ). When this image was merged with DNA staining (Fig. 9B ) a yellow colour indicating colocalization was obtained in the perinuclear region and also scattered through the nucleus (Fig.   9C ). There was also a dotted yellow pattern in the cytosol, which might correspond to mitochondria as they also contain DNA. The presence of Sptrx-2 in nucleus is not likely to be an artefact as a control with Sptrx-1 or Txl-2 GFP fusion constructs had a clear cytosolic localization with no nuclear fluorescent signal (A. Miranda-Vizuete, unpublished results) and the subcellular localization of the Sptrx-2/GFP fusion protein in vivo was similar to that of fixed cells (data not shown). In addition, it is important to point out that Sptrx-2 sequence analysis on PSORT II program (http://psort.ims.u-tokyo.ac.jp/form2.html) identified two putative pat7 nuclear targeting sequences centred at residues 50 (PLFRKLK) and 308 (PDFKKMK), respectively (Hicks & Raikhel 1995) , and a putative mitochondrial pre-sequence cleavage site at residue 16 (REVQLQTVINN QS), although the overall prediction is cytosolic (Gavel & von Heijne 1990) . These data might explain the pattern obtained with the Sptrx-2/GFP fusion protein.
DISCUSSION
The first form of thioredoxin (now termed Trx-1) was described in E. coli as early as 1964 (Laurent et al. 1964) whereas the identification of the mammalian mouse and human homologues had to wait for 25 years (Tagaya et al. 1989; Wollman et al. 1988 ). Since 1996 our group has been engaged in the search of novel members of the thioredoxin family of proteins, which resulted in the identification of a mitochondrial thioredoxin system (Trx-2 and TrxR2), a ubiquitous thioredoxin-like protein of unknown function (Txl-1) and the first tissue-specific member of the family in human spermatozoa (Sptrx-1) (Miranda-Vizuete et al. 2000; Miranda-Vizuete et al. 1998; Miranda-Vizuete et al. 2001) . All known thioredoxins fall into two groups depending on whether they are composed of only a thioredoxin domain, (Trx-1 and Trx-2, Group I) or have additional domains (Txl-1 and Sptrx-1, Group II). We report here the identification of the second tissue-specific member of the family, named Sptrx-2, also in male germ cells.
Sptrx-2 is organized into one N-terminal thioredoxin domain followed by three NDP kinase domains, the first of them incomplete. A similar protein arrangement has been described for IC1, a sea urchin protein which has been classified as one of the three intermediate chains of axonemal outer arm dynein sperm axoneme (Ogawa et al. 1996) . Thus IC1 is also composed of a thioredoxin domain, three tandemly repeated NDP kinase domains and only differs from Sptrx-2 in a C-terminal part rich in glutamic acid residues. Sptrx-2 has been proposed to be the human homologue of IC1 based on sequence similarity . The occurrence of thioredoxin domains in other flagellar proteins have also been reported in outer arm dynein light chains DLC14 and DLC16 from Chlamydomonas flagella (Patel-King et al. 1996) .
However, to our knowledge, thioredoxin activity has not been properly assayed in these flagellar proteins. In our study, we have failed to detect any enzymatic thioredoxin activity when assaying recombinant full-length Sptrx-2 (expressed in bacteria) with NADPH and calf thymus thioredoxin reductase or DTT. Only when expressing the thioredoxin domain alone we were able to detect a significant activity in the DTT assay. The acquisition of a thioredoxin domain in flagellar proteins occurs early in evolution and is most likely a consequence of molecular or enzymatic requirements for a specific function in flagellum movement (Patel-King et al. 1996) .
The lack of thioredoxin activity in Sptrx-2 most probably depends on its threedimensional structure, not only of the full-length protein but also of the thioredoxin domain itself that impedes the access of the natural catalyst thioredoxin reductase to its active site. This implies that another mechanism might operate to maintain Sptrx-2 in an active reduced state. One possible explanation is the newly described TRG, a fusion protein of a glutaredoxin and a thioredoxin reductase module which is highly expressed in testis and might function as a reducing system for Sptrx-2 (Sun et al. 2001) . Alternatively, phosphorylation is one of the most well-established cellular mechanisms by which a conformational change in a protein is achieved (Cohen 2000) and the major regulatory pathway in testis and sperm physiology (Eddy & O´Brien 1994) . Sptrx-2 has multiple phosphorylation sites and one might speculate that phosphorylation of the protein could induce a conformational change that would make the thioredoxin active site accessible to thioredoxin reductase.
The Sptrx-2 thioredoxin domain is followed by one incomplete (lacking the active site) and two complete NDP kinase domains at the C-terminus of the protein (domains A, B and C respectively). NDP kinases catalyze the transfer of γ-phosphates between tri-and diphosphonucleosides and are autophosphorylated as an intermediate in the reaction (Biondi et al. 1996) . This autophosphorylation has been
shown to occur at the Nδ position of the conserved histidine of the active site NXXH.
While the NDPk-C domain has this conserved active site sequence, the B domain lying in the middle of the tandem has the histidine substituted by a tyrosine residue, which is also phosphorytable thus suggesting possible novel features in the catalytic mechanism. As with the thioredoxin activity, we have not been able to identify any autophosphorylation activity in Sptrx-2, which is also the case of the other NDP kinase specifically expressed in testis, nm23-H5 (Munier et al. 1998) . Taken together, the lack of both thioredoxin and kinase activities in Sptrx-2 while the structures of the respective domains are so conserved might suggest that interaction with other proteins or cofactors is needed for Sptrx-2 to function.
Sptrx-2 protein expression is restricted to spermiogenesis, being detected in pachytene spermatocytes, round and elongating spermatids within human seminiferous tubules. In mature human sperm Sptrx-2 is mostly found in the tail, further supporting the hypothesis of being the human homologue of sea urchin IC1
protein. The synthesis of the sperm cytoskeletal polypeptides, has been shown to occur in the cytoplasm of spermatids, which is consistent with the expression pattern obtained for Sptrx-2 and corresponds to the growth of the structures that organize the sperm tail, including the axoneme (Oko 1998) . Taken together, it is reasonable to assume that Sptrx-2 might be a component of the human sperm axonemal machinery and therefore be a candidate gene to several male infertility phenotypes.
With this aim we first screened the Mendelian Cytogenetics Network Database (http://mcndb.imbg.ku.dk/) to determine whether any breakpoint in the region where Sptrx-2 maps has been reported to be associated with an infertility phenotype.
We found four reported breakpoints mapping at Sptrx-2 locus and, interestingly, three of them had an associated trait of infertility (accession ID number: 702748, 702844 and 702852). Primary ciliary dyskinesia (PCD) is an autosomal recessive disorder (OMIM 242650) characterized by a failure of proper ciliary and flagellar movement whose clinical manifestations are chronic respiratory infections, male infertility and situs inversus (Blouin et al. 2000; Cowan et al. 2001) . The motility of cilia and flagella is generated in the axoneme which has been estimated to be composed of more than 250 polypeptides (Dutcher 1995 (Neesen et al. 1997; Milisav et al. 1996) as a testis specific α-tubulin has been identified in mice (Distel et al. 1984) . Dynein arm deficiency (DAD) is a subgroup of PCD and a recent linkage analysis has identified 7p, the region where Sptrx-2 maps, as a potential genomic region harbouring gene(s) involved in DAD (Blouin et al. 2000) . Thus, similarity with sea urchin IC1, male germ cell specific expression and chromosomal mapping in candidate regions for male infertility phenotypes suggest that Sptrx-2 is a gene coding for a sperm axonemal specific form of dynein arm and therefore a good candidate for male infertility diseases associated with primary ciliary dyskinesia.
Further work is in progress to decipher the functional role of Sptrx-2 in human spermatogenesis which will shed more light on the newly discovered subset of thioredoxin proteins with a testis specific expression. . The cloning, overexpression and purification of the truncated form of human Sptrx-2 (h∆Sptrx-2) was identical to that described for the full-length protein except that the ion exchange purification step was not required as the protein eluted in a pure form following thrombin cleavage.
EXPERIMENTAL PROCEDURES

Enzymatic activity assays.
Two different assays were used to determine the enzymatic activity of human Sptrx-2, both based on the ability of the protein to reduce insulin disulfide bonds in vitro. In the DTT assay, DTT is used as reductant and the assay was carried out as previously described (Wollman et al. 1988) . Briefly, thioredoxin and was performed essentially as described elsewhere (Spyrou et al. 1997) . Briefly, aliquots of Sptrx-2 and ∆Sptrx-2 were preincubated at 37 °C for 20 min with 2 µl of: 50 mM Hepes, pH 7.6, 100 µg/ml bovine serum albumin, and 2 mM DTT in a total volume of 70 µl. This step allows total reduction of the protein. Then, 40 µl of a reaction mixture composed of 200 µl of Hepes (1 M), pH 7.6, 40 µl of EDTA (0.2 M), 40 µl of NADPH (40 mg/ml), and 500 µl of insulin (10 mg/ml) were added. The reaction was initiated by the addition of 10 µl of thioredoxin reductase from calf thymus (3.0 A412 unit), and incubation was continued for 20 min at 37 °C. The reaction was stopped by the addition of 0.5 ml of 6 M guanidine-HCl, 1 mM DTNB, and the absorbance at 412 nm was measured. In both assays human Trx-1 was used as control.
Human Sptrx-2 in situ hybridization analysis: Riboprobes (sense and antisense) were generated from Sptrx-2 ORF template using Preparation of spermatozoa and extraction of sperm proteins. Semen samples from healthy donors were allowed to liquefy at room temperature and separated from seminal plasma by centrifugation (1000 x g) for 10 min at room temperature.
After two washes in PBS the pelleted spermatozoa were frozen at -20°C until use.
The sperm pellet was solubilized in a lysis buffer containing Tris-HCl 0.1 M pH 8.0, NaCl 0.15 M, protease inhibitor cocktail (Boehringer Mannheim) and phosphatase inhibitor cocktail (SIGMA) at the concentration recommended by the manufacturers.
Samples were then subjected to three cycles of freezing/thawing in dry ice-ethanol, incubated for 30 min on ice and centrifuged at 14000 rpm for 30 min. The soluble fraction was used for further analysis.
Antibody production, immunoblotting analysis and immunocytochemistry.
Purified GST-hSptrx-2 was used to immunize rabbits (Zeneca Research Biochemicals). After six immunizations, serum from rabbits was purified by ammonium sulfate precipitation. Affinity purified antibodies were prepared using a cyanogen bromide-activated Sepharose 4B column, onto which 0.5 mg recombinant Sptrx-2 fragment had been coupled using the procedure recommended by the manufacturer (Pharmacia). Specificity of the antibodies was tested by western blotting using recombinant Sptrx-2 and total cell extracts. Green fluorescent protein analysis. We used the pEGFP-N 3 vector (Clontech) to express the GFP at the C-terminus of hSptrx-2. For that purpose we used the mutagenic primers GFP-F1 (5'-GTTGAATTCGCCACCATGGCAAGCAAAAAAC-3´)
as forward primer and GFP-R1 (5'-GTTTTCCTCAGGATCCCTCAAAGAGTCTATT-3') as reverse primer to amplify human Sptrx-2 from pGEM-T/hSptrx-2. The forward primer introduces an EcoRI site followed by a Kozac sequence (Kozak 1996) (Thompson et al. 1994) . Identical residues are shadowed and thioredoxin active site sequence CGPC is shown in bold and boxed.
Numbers are referred to those of human Trx-1 (Wollman et al. 1988) . were assayed for its ability to reduce insulin disulfide bonds using DTT as electron donor: (O) Trx-1 at 5 µM, (q) ∆Sptrx-2 at 25 µM, (∆) ∆Sptrx-2 at 5 µM, ( ), Sptrx-2 at 25 µM. The reaction was initiated by adding 1 µl of 100 mM DTT and followed for 30 min at 30ºC. 
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